default author photo

Laura Basterretxea

affiliation not provided to SSRN

  • affiliation not provided to SSRN

SCHOLARLY PAPERS

1

DOWNLOADS

40

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Randomized phase II trial of nivolumab plus paclitaxel in subjects with recurrent/metastatic head and neck squamous cell carcinoma unable for cisplatin-based chemotherapy. NIVOTAX TTCC study

Number of pages: 22 Posted: 15 Jan 2026
Lara Iglesias, Neus Basté, Marc Oliva, Alberto Carral, Pedro Pérez Segura, Ana Medina-Colmenero, Beatriz Cirauqui Cirauqui, Virginia Arrazubi, Javier Martínez-Trufero, Vanesa Gutiérrez Calderón, Almudena García Castaño, Jordi Rubio Casadevall, Edel del Barco, Laura Basterretxea, Gema Bruixola, Ruth Álvarez Cabellos, María José Flor, Irene Brana, Javier Caballero, Joaquina Martínez, Julio Lambea, Xavier Perez-Martin, Carmen Montalbán, Marisa Duran and Ricard Mesia
Instituto de Investigación Sanitaria Hospital "12 de Octubre" - Hospital Universitario 12 de Octubre, affiliation not provided to SSRN, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, affiliation not provided to SSRN, Hospital Clinico San Carlos, affiliation not provided to SSRN, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Hospital Universitario de Navarra, affiliation not provided to SSRN, Hospital Regional Universitario de Málaga, affiliation not provided to SSRN, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Complejo Hospitalario Universitario de Toledo, affiliation not provided to SSRN, Vall d’Hebron Institute of Oncology (VHIO), Hospital Universitari i Politècnic La Fe, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and Autonomous University of Barcelona - Medical Oncology Department
Downloads 40 (1,183,237)

Abstract:

Loading...

Head and neck, squamous cell carcinoma, unfit, frail, chemotherapy, immunotherapy